gland pharma glp-1 manufacturing capacity India's pharmaceutical industry is witnessing another massive strategic move 💊📈 Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a ₹1,369 crore deal, signaling stronger expansion, integrated Complex Pharma: Waiting by the

My case is fully defensible My patient is demanding an unwarranted refund How do I safely terminate doctor-patient relationship

The product should not be used by children, pregnant women, or breastfeeding mothers

#CardiovascularDrugs #Cardiology #HeartHealth #PharmaceuticalIndustry #CardiovascularDisease #PharmaInnovation To view or add a comment, sign in : : The biosimilars market is expected to reach USD 72.29 billion by 2035 from USD 35.04 billion in 2025, at a CAGR of 7.5% during the forecast period

More serious side effects can occur, although they are less common

30.Bjrky, G., Lamark, T., Brech, A., Outzen, H., Perander, M., et al

Gros R, You X, Baggio LL, Kabir MG, Sadi AM, Mungrue IN, et al